1-5 of 5
Jean-Philippe Vuillez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

Clinical Trials & Observations
Thierry Lamy, Gandhi Damaj, Pierre Soubeyran, Emmanuel Gyan, Guillaume Cartron, Krimo Bouabdallah, Rémy Gressin, Jérôme Cornillon, Anne Banos, Katell Le Du, Mohamed Benchalal, Marie-Pierre Moles, Steven Le Gouill, Joel Fleury, Pascal Godmer, Hervé Maisonneuve, Eric Deconinck, Roch Houot, Kamel Laribi, Jean Pierre Marolleau, Olivier Tournilhac, Bernard Branger, Anne Devillers, Jean Philippe Vuillez, Thierry Fest, Philippe Colombat, Valérie Costes, Vanessa Szablewski, Marie C. Béné, Vincent Delwail
Journal: Blood
Blood (2018) 131 (2): 174–181.
https://doi.org/10.1182/blood-2017-07-793984
Published: 2018
Includes: Supplemental data
Journal Articles

PET Adapted Salvage Therapy for Advanced Hodgkin Lymphomas: Towards the Suppression of Positive Interim PET Unfavorable Prognosis? a Report of the Goelams Multicentric Phase 2 Trial LH2007

Sylvain Carras, MD, Benjamin Dubois, Delphine Senecal, MD, Philippe Quittet, MD, jean-Philippe Vuillez, MD PhD, Michel peoc'H, MD PhD, jean-Philippe Jais, Thierry Lamy, MDPhD, Lysiane Molina, MD
Journal: Blood
Blood (2015) 126 (23): 3932.
https://doi.org/10.1182/blood.V126.23.3932.3932
Published: 2015
Journal Articles

Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT

Julien Dubreuil, Roch Houot, MD PhD, Steven Le Gouill, Christiane Mounier, MD, Stéphane Courby, MD, Caroline Dartigeas, MD, Krimo Bouabdallah, MD, Marie Pierre Moles, MD, Alexis Magda, Olivier Tournilhac, MD, Mario Ojeda Uribe, Jean Cyril Bourre, Caroline Bodet-Milin, MD, Jean-Philippe Vuillez, MD PhD, Remy Gressin, MD
Journal: Blood
Blood (2014) 124 (21): 3070.
https://doi.org/10.1182/blood.V124.21.3070.3070
Published: 2014
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90 y-Epratuzumab Tetraxetan Following R-CHOP in Elderly DLBCL Patients: A Lysa Phase II Prospective Trial

Françoise Kraeber-Bodere, MD, PhD, Amandine Pallardy, MD, Steven Le Gouill, Hervé Maisonneuve, MD, Thierry Lamy, MD, Krimo Bouabdallah, MD, Noel Milpied, MD, Henry Jardel, MD, Eric Deconinck, MD, PhD, Nadine Morineau, MD, Charles Foussard, MD, Annie Brion, MD, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, MD, Christian Berthou, MD, Francois Dreyfus, Caroline Bodet-Milin, MD, Anne-Laure Cazeau, MD, Etienne Garin, MD, PhD, Jean-Philippe Vuillez, MD, PhD, Loic Campion, MD, Philippe Moreau, MD, William A Wegener, MD, PhD, David M Goldenberg, ScD, MD, Pierre Soubeyran, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 906.
https://doi.org/10.1182/blood.V120.21.906.906
Published: 2012
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010